“The European Union’s vaccine dispute has escalated again!” According to a report on the 10th by Der Spiegel, the President of the European Council Michel on the 9th refuted allegations of “vaccine nationalism” against the EU, saying that although the United Kingdom and the United States are two major vaccine producers The export of the new crown vaccine has been completely banned, but the EU has not done so. This remark immediately caused dissatisfaction in Britain. British Prime Minister Johnson solemnly stated in Parliament on the 10th that Britain has not banned the export of vaccines. In addition, because the EU’s efforts in supplying vaccines to developing countries so far are not as good as China, Russia or India, Michel has pointed the finger at China and Russia, saying that China and Russia use vaccines for “vaccine diplomacy” and calling on other countries not to Was misled, claiming that the EU would not follow suit. According to a report by Bloomberg on the 9th, the EU vaccine passport may open the door to Chinese and Russian vaccines.
Last week, the European Union approved Italy’s decision to suspend export of 250,000 doses of the new crown vaccine to Australia, which annoyed overseas vaccine buyers, who criticized the European Union for its “vaccine nationalism”. In this regard, Michelle said on the 9th that the EU has never stopped the export of vaccines, and the above decision is to prevent manufacturers from failing to comply with the contract and first export vaccines to other developed countries. At the same time, Michel pointed out that the United Kingdom and the United States have completely banned the export of vaccines and related raw materials. He expressed the hope that the United Kingdom can increase the transparency of vaccine exports to the European Union and third countries. Regarding Michelle’s remarks, the United Kingdom quickly retorted that the United Kingdom did not prevent the export of any vaccine. A spokesman for the British government said: “Any statement about the UK vaccine export ban or restriction is completely wrong.” The EU representative to the UK was also called to the British Foreign Office on Tuesday night.
This is the second time since the beginning of this year that the United Kingdom and the European Union have disputed over the production and sales of the new crown vaccine. Due to concerns about vaccine supply, the European Union announced on January 29 the implementation of the “transparent vaccine export mechanism.” This mechanism requires all companies that produce vaccines within the EU to obtain a license from the government of the country where they are exporting vaccines outside the EU. This move sparked a debate between the UK and the European Union over the Northern Ireland Protocol reached by the two sides last year, because the export control system may affect the delivery of vaccines to Northern Ireland. For the United States, the European Union also requires the other party to approve millions of doses of AstraZeneca vaccine produced in the United States to be exported to Europe to solve the problem of insufficient supply, so as not to affect the European Union’s vaccination plan.
On the 11th, the European Medicines Agency will approve the single-dose new crown vaccine developed by Johnson & Johnson in the United States, and it is expected to be approved for use. The European Union previously signed a 200 million dose vaccine supply agreement with Johnson & Johnson, and it is expected to begin delivery in installments next month. However, according to EU officials, Johnson & Johnson could only deliver 55 million doses due to a shortage of production materials and equipment, or difficulty in meeting its supply targets. However, the EU and Pfizer have reached an agreement that the company will supply another 4 million doses of the new crown vaccine to member states in the next two weeks.
Due to the slow delivery of vaccine manufacturers. Individual EU member states have turned to the Russian “Satellite-V” vaccine and the Chinese National Medicine vaccine that have not been approved by the EU health agency. The Czech Republic and Slovakia have also ordered a certain number of Russian “Satellite-V” vaccines. The Italian-Russian Chamber of Commerce stated on the 9th that the Russian Direct Investment Fund has signed a contract with Swiss Adeen Pharmaceuticals to produce the Russian-developed “Satellite-V” vaccine in Italy. This is the first time that a Russian new crown vaccine has been produced in an EU country. The European Medicines Agency began to approve the Russian “Satellite-V” vaccine last week. If approved, production will start in Italy in July. The two parties expect that 10 million doses of vaccine will be produced by January 1 next year.
According to the latest data from Oxford University’s “OurWorldinDa-ta” project team, the proportion of people in the UK who have received at least one dose of the vaccine is currently as high as one-third, the United States has reached 17.9%, and the EU has averaged only 6.5%. Many EU countries accuse the European Commission’s “new crown strategy” for slow progress, and even believe that the European Commission’s President von der Lein should be responsible. In this regard, the European Union referred the problem to vaccine manufacturers. Von Delane warned on the 8th that after the Italian government blocked 250,000 doses of AstraZeneca’s new crown vaccine from being exported to Australia, the EU may further block the export of new crown vaccine.
Although the speed of vaccination lags behind that of the United Kingdom and the United States, the European Union is trying to catch up, including the upcoming vaccine passport program. Bloomberg reported on the 9th that a person familiar with the relevant draft of the European Commission said that the “EU Vaccine Passport” to be launched in March consists of three documents that determine whether the holder is vaccinated, its variety, and the new crown virus test result. (If tested) and whether the holder has recovered from the new coronary pneumonia infection. A source said that the EU vaccine passport may cover all vaccines, including vaccines approved by the European Medicines Agency or urgently authorized to use in individual EU countries. For example, Hungary has begun to vaccinate vaccines produced in China and Russia. But for some member states, including vaccines that are not authorized by Europe in their passports may cause controversy. Last month, EU leaders agreed on the outline of the draft vaccine passport plan. For countries that rely on tourism, such as Greece and Cyprus, the launch of the plan has become a top priority.